Inventor
MACAGNO ANNALISA
CH38 patents
⚠️ This page may combine multiple inventors who share the name “MACAGNO ANNALISA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNOQURE AG
9 patentsUS9475872B2Oct 25, 2016
Nucleic acid molecules encoding moonoclonal antibodies speceific for IL17F
IMMUNOQURE AG5 citations81
US10131709B2Nov 20, 2018
Nucleic acid molecules encoding monoclonal antibodies specific for IL-22
IMMUNOQURE AG4 citations70
US10112995B2Oct 30, 2018
Human anti-IFN-α antibodies
IMMUNOQURE AG4 citations70
US10081676B2Sep 25, 2018
Human anti-IL-32 antibodies and methods of making and using the same
IMMUNOQURE AG4 citations70
US9957319B2May 1, 2018
Method of isolating human antibodies
IMMUNOQURE AG3 citations70
US10975144B2Apr 13, 2021
CDNA encoding a monoclonal anti-IL-32 antibody and methods for the production of the antibody
IMMUNOQURE AG0 citations60
US11945861B2Apr 2, 2024
Human anti-IFN-α antibodies
IMMUNOQURE AG0 citations59
US10941198B2Mar 9, 2021
Human anti-IFN-α antibodies
IMMUNOQURE AG1 citations59
US10875916B2Dec 29, 2020
Nucleic acid molecules encoding monoclonal antibodies specific for IL-17F
IMMUNOQURE AG0 citations49
LANZAVECCHIA ANTONIO
8 patentsUS8124093B2Feb 28, 2012
Human cytomegalovirus neutralizing antibodies and use thereof
LANZAVECCHIA ANTONIO41 citations98
US8435524B2May 7, 2013
Human cytomegalovirus neutralizing antibodies and use thereof
LANZAVECCHIA ANTONIO16 citations96
US8298539B2Oct 30, 2012
Human cytomegalovirus neutralizing antibodies and use thereof
LANZAVECCHIA ANTONIO23 citations96
US8287870B2Oct 16, 2012
Human cytomegalovirus neutralizing antibodies and use thereof
LANZAVECCHIA ANTONIO25 citations96
US9217028B2Dec 22, 2015
Human cytomegalovirus neutralising antibodies and use thereof
LANZAVECCHIA ANTONIO12 citations92
US8603480B2Dec 10, 2013
Human cytomegalovirus neutralizing antibodies and use thereof
LANZAVECCHIA ANTONIO14 citations92
US8309089B2Nov 13, 2012
Human cytomegalovirus neutralising antibodies and use thereof
LANZAVECCHIA ANTONIO20 citations92
US8298538B2Oct 30, 2012
Human cytomegalovirus neutralising antibodies and use thereof
LANZAVECCHIA ANTONIO16 citations92
INST RESEARCH IN BIOMEDICINE
7 patentsUS9127049B2Sep 8, 2015
Human cytomegalovirus neutralizing antibodies and use thereof
INST RESEARCH IN BIOMEDICINE16 citations96
US9371372B2Jun 21, 2016
Human cytomegalovirus neutralizing antibodies and use thereof
INST RESEARCH IN BIOMEDICINE10 citations92
US9365636B1Jun 14, 2016
Human cytomegalovirus neutralizing antibodies and use thereof
INST RESEARCH IN BIOMEDICINE10 citations92
US9249213B2Feb 2, 2016
Human cytomegalovirus neutralizing antibodies and use thereof
INST RESEARCH IN BIOMEDICINE12 citations92
US9221897B2Dec 29, 2015
Human cytomegalovirus neutralizing antibodies and use thereof
INST RESEARCH IN BIOMEDICINE12 citations92
US9149524B2Oct 6, 2015
Human cytomegalovirus neutralising antibodies and use thereof
INST RESEARCH IN BIOMEDICINE12 citations92
US8765132B2Jul 1, 2014
Human cytomegalovirus neutralizing antibodies and use thereof
INST RESEARCH IN BIOMEDICINE14 citations92
INST FOR RES IN BIOMEDICINE
7 patentsUS9527902B2Dec 27, 2016
Human cytomegalovirus neutralizing antibodies and use thereof
INST FOR RES IN BIOMEDICINE9 citations92
US9491906B2Nov 15, 2016
Human cytomegalovirus neutralizing antibodies and use thereof
INST FOR RES IN BIOMEDICINE7 citations92
US9803000B1Oct 31, 2017
Human cytomegalovirus neutralizing antibodies and use thereof
INST FOR RES IN BIOMEDICINE3 citations84
US9796771B2Oct 24, 2017
Human cytomegalovirus neutralizing antibodies and use thereof
INST FOR RES IN BIOMEDICINE3 citations84
US9796772B2Oct 24, 2017
Human cytomegalovirus neutralizing antibodies and use thereof
INST FOR RES IN BIOMEDICINE3 citations84
US9725502B2Aug 8, 2017
Human cytomegalovirus neutralizing antibodies and use thereof
INST FOR RES IN BIOMEDICINE4 citations84
US9611316B2Apr 4, 2017
Human cytomegalovirus neutralising antibodies and use thereof
INST FOR RES IN BIOMEDICINE4 citations84
INST RES BIOMEDICINE
3 patentsUS10040845B2Aug 7, 2018
Human cytomegalovirus neutralizing antibodies and use thereof
INST RES BIOMEDICINE2 citations84
US10889632B2Jan 12, 2021
Human cytomegalovirus neutralizing antibodies and use thereof
INST RES BIOMEDICINE0 citations73
US10414817B2Sep 17, 2019
Human cytomegalovirus neutralizing antibodies and use thereof
INST RES BIOMEDICINE1 citations73